Visit ECRI Institute at booth 417 during the ISPOR 22nd Annual International Meeting to learn how to make evidence-informed decisions on health technologies. Whether you need help navigating the complex world of genetic tests or are seeking evidence to inform coverage and implementation decisions, our experts are uniquely qualified to assist you.
Ask us about these evidence-based services:
Health Technology Assessment—Customized research support and membership-based information services for evidence-based decision making on medical devices, drugs, and procedures
ECRIgeneTM—New, dynamic genetic test resource to guide evidence-based clinical policy and utilization decisions
About the ISPOR 22nd Annual International Meeting
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting offers attendees the opportunity to discuss the latest innovative research methods, learn from experts about clinical, economic, and patient-reported outcomes, and network with others in the health economics and outcomes research (HEOR) field.
For more information, or if you would like to set up an on-site meeting with one of our specialists, please contact us at email@example.com.